Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial
Titel:
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial
Auteur:
Yong, Kwee Wilson, William de Tute, Ruth M Camilleri, Marquita Ramasamy, Karthik Streetly, Matthew Sive, Jonathan Bygrave, Ceri A Benjamin, Reuben Chapman, Michael Chavda, Selina J Phillips, Elizabeth H del Mar Cuadrado, Maria Pang, Gavin Jenner, Richard Dadaga, Tushhar Kamora, Sumaiya Cavenagh, James Clifton-Hadley, Laura Owen, Roger G Popat, Rakesh
Verschenen in:
The Lancet. Haematology
Paginering:
Jaargang 10 () nr. 2 pagina's e93-e106
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license